HistoRx Recognized as a 2010 Company to Watch by the Connecticut Technology Council
BRANFORD, Conn., Oct. 4 /PRNewswire/ -- HistoRx was recognized as a 2010 Company to Watch by the Connecticut Technology Council at the Innovation Pipeline Awards ceremony last week in New Haven, Connecticut. HistoRx was recognized for significant milestones achieved in 2010:
- launching its proprietary AQUA® technology software on a second hardware platform -- the ScanScope FL from Aperio
- signing a licensing deal with a national oncology reference lab for AQUA technology and several diagnostic assays based on it -- Genoptix Medical Laboratory (Nasdaq: GXDX)
- receiving a U.S. patent for an application of AQUA technology to personalized medicine -- methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers, specifically thymidylate synthase (TS)
These achievements represent key indicators of the company's maturation from a life science technology company to a diagnostics developer nearing first clinical use of its products.
The Innovation & Entrepreneurship Summit is a juried event designed to showcase the products and services from approximately 100 exciting early stage companies in various advanced technology categories. Each year the event draws several hundred investors, corporate business development executives, prospective customers and the media. This multifaceted event included a technology showcase of the award-winning Companies to Watch, and focused on young, emerging technology companies with an innovative product or service and the potential to grow quickly.
The Connecticut Technology Council is a statewide association of technology oriented companies and institutions, providing leadership in areas of policy advocacy, community building and assistance for growing companies. Speaking for over 2,000 companies that employ some 200,000 residents, the Connecticut Technology Council seeks to